Drug Therapy

The Oncology Outpatient Clinic and Infusion Outpatient Clinic are responsible for patients' outpatient care medication, and for some patients, monitoring after the therapy.

  • Hormone therapy is ideal for specific, hormone sensitive cancers, such as breast cancer. In most cases, hormone therapy does not cause notable adverse effects.
  • In many types of cancers, cytotoxic chemotherapy is an important part of curative, and in some cases also of palliative treatment. Cytotoxic drugs are continuously being developed. Cytotoxic chemotherapy is related to a varying degree of adverse effects, which can be reduced by premedication, such as antiemetics.
  • New targeted therapies (so-called smart drugs) include antibodies and small-molecule drugs. Antibodies are used for example in the treatment of breast cancer, lymphomas and bowel cancer. Small-molecule drugs are used to treat kidney and lung cancer.
  • Patients may also participate in clinical cancer drug trials, in which they have the opportunity to receive new medication not yet otherwise available. Participation in a clinical study is always voluntary. If a patient does not wish to participate in the clinical study introduced, he/she will be treated according to the existing clinical guidelines.

Contact Information

Oncology Outpatient Clinic 3651
Puijo Hospital, Säde Hospital,
floor 4
Ward Secratary,
tel. (+358) 17 172 940
Mon–Fri 8 a.m.– 11 a.m.
Nurses tel. (+358) 17 172 945
Mon-Fri 8 a.m.– 2 p.m.

Infusion Outpatient Clinic
Puijo Hospital, Säde Hospital,
floor 4
Ward Secretary,
tel. (+358) 17 173 937
Mon–Thu 8 a.m.– 3 p.m.,
Fri 9 a.m.– 3 p.m.